10762171 · Active · incorporated 9 years, 5 months ago · Altrincham
Biotech Biotech & Life Sciences Deep Tech Drug Discovery Series B+
NeoPhore is a biotechnology company focused on developing small molecule immuno-oncology therapeutics that target the DNA mismatch repair pathway to treat cancer.
Neophore Limited is a private limited company registered at Companies House under number 10762171, incorporated on 9 May 2017, with a registered office in Altrincham, Cheshire. Its current status on the register is active. Its filed nature of business is research and experimental development on biotechnology (SIC 72110). Sonde has indexed 106 filings for this company, including 6 funding rounds. Its most recent round closed in April 2024, raising £14.6m.
| Round | Closed | Raised | Price per share |
|---|---|---|---|
| Round 6 | Apr 2024 | £14.6m | £17.05 |
| Round 5 | Dec 2022 | £5.7m | £17.05 |
| Round 4 | Jan 2022 | £9.6m | £16.24 |
| Round 3 | Feb 2021 | £7.2m | £13.11 |
| Round 2 | Jan 2020 | £1.5m | £34.29 |
| Round 1 | Nov 2018 | £1.5m | £34.29 |
Showing the 10 most recent of 106 filings.
See the complete cap table with every shareholder, founder tags, dilution across 23 share allotments, round-by-round fundraising history, and the full filing timeline — parsed from official Companies House documents.
Create a free account Sign inFree accounts open 3 companies in full detail — no card required.